New shot tested for Tough-to-Treat arthritis
NCT ID NCT07230353
Summary
This early-stage study is testing the safety and side effects of a new drug called plamotamab in adults with moderate to severe rheumatoid arthritis. About 47 participants who haven't responded well to standard arthritis medications will receive injections of the drug at different dose levels. The main goal is to see how well people tolerate the treatment and to understand how the drug behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Arensia Research Clinic
NOT_YET_RECRUITINGTbilisi, Georgia
-
Arensia Research Clinic
RECRUITINGChisinau, Moldova
-
Xencor Investigative Site
NOT_YET_RECRUITINGTbilisi, Georgia
-
Xencor Investigative Site
NOT_YET_RECRUITINGAuckland, New Zealand
Conditions
Explore the condition pages connected to this study.